MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment"

  • 2022 International Congress

    An unusual cause of choreoathetosis: PRES and Goodpasture’s Syndrome

    M. Bonello, M. Cauchi, R. Debono, N. Vella (Pieta, Malta)

    Objective: Our aim is to shed light on an usual cause of choreoathetosis in a medically complex case. Background: Goodpasture’s syndrome(GBS) is a rare autoimmune…
  • 2022 International Congress

    Long-term Deutetrabenazine Safety on Motor, Psychiatric, and Cognitive Measures in Individuals With Chorea Associated With Huntington Disease

    M. Gordon, D. Stamler, J. Savola, N. Gross, H. Barkay, M. Chen, N. Chaijale (West Chester, USA)

    Objective: To evaluate long-term deutetrabenazine safety on motor, psychiatric, and cognitive measures in participants with chorea associated with Huntington disease (HD). Background: Deutetrabenazine, a vesicular…
  • 2022 International Congress

    Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity

    V. Sung, E. Furr Stimming, S. Reshef, R. Willock, R. Ribalov, S. Brighton, S. Leo (Birmingham, USA)

    Objective: To describe baseline characteristics and treatment patterns in patients with chorea associated with Huntington disease (HD) by severity of chorea. Background: Though multiple treatment…
  • 2022 International Congress

    4 YEARLONG POST PARTUM AUTOIMMUNE CHOREA AS INITIAL PRESENTATION OF INCOMPLETE SLE/APS

    W. Trillo Alvarez, J. Medina Suárez, J. Molina Acosta, A. Escalante Mercado, C. Ibañez Escalante, E. Carrillo Monteagudo, V. Medina Cerpa, E. Ramos Luza, P. Gonzales Romero, G. García Huamán (AREQUIPA, Peru)

    Objective: The aim is to report a case of a 4 yearlong postpartum autoimmune chorea secondary to incomplete SLE/APS. Background: Chorea is a movement disorder…
  • MDS Virtual Congress 2021

    Healthcare utilization in individuals with late onset versus adult-onset Huntington’s disease

    J. Ta, TM. To, A. Patel, I. Abbass, S. Arndorfer, R. Ghandy (South San Francisco, USA)

    Objective: To assess healthcare utilization (HCU) among patients (pts) with late-onset Huntington’s disease (LoHD) versus adult-onset HD (AoHD) and non-HD controls. Background: HD typically manifests…
  • MDS Virtual Congress 2021

    Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease

    J. Ta, S. Reiss Reddy, E. Chang, A. Exuzides, R. Gandhy, G. Yohrling (South San Francisco, USA)

    Objective: Examine healthcare resource utilization (HRU) and costs among US Medicare beneficiaries with late-onset Huntington’s disease (LoHD). Background: Huntington’s disease (HD) is a genetic, neurodegenerative…
  • MDS Virtual Congress 2021

    Primary Palliative Care for Huntington Disease

    M. Harrison, D. Morrissey, F. Daly (Charlottesville, VA, USA)

    Objective: To develop a pilot program integrating primary palliative care with interdisciplinary care for Huntington disease (HD). Goals: 1) train HD team members to facilitate…
  • MDS Virtual Congress 2021

    Reversible hemichorea due to contralateral anterior cerebral artery territory hypoperfusion

    S. Adukia, P. Shah, M. Shrivastava, G. Sangani, D. Sanghvi, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: We report hemichorea due to hypoperfusion of the contralateral anterior cerebral artery (ACA) territory (including caudate nucleus and its connections) that reversed with revascularization.…
  • MDS Virtual Congress 2021

    Medically refractory Graves’ disease presenting as chorea and carbohydrate hyperphagia in a Kenyan adolescent

    N. Mongare, E. Njenga, D. Sokhi (Nairobi, Kenya)

    Objective: To report a unique case of adolescent-onset autoimmune hyperthyroidism presenting with chorea and carbohydrate hyperphagia (CH). Background: Autoimmune hyperthyroidism [Graves’ disease (GD)] can cause…
  • MDS Virtual Congress 2021

    Predictors of Persistence to Deutetrabenazine Among Patients With Tardive Dyskinesia (TD) and Huntington’s Disease (HD)

    D. Claassen, R. Ayyagari, V. Garcia-Horton, S. Zhang, S. Leo (Nashville, USA)

    Objective: To identify real-world predictors of persistence to deutetrabenazine in patients with TD or HD. Background: Deutetrabenazine is FDA-approved to treat TD in adults and…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Kratom withdrawal induced orobuccal dyskinesia
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley